邱林,龚艳君

• 1:北京大学第一医院心内科

摘要(Abstract)：

<正>一、血栓弹力图概述血栓弹力图(thrombelastography,TEG)由德国Hartert等[1]于上世纪40年代发明,最早被用来监测外科手术的出血风险并评估输注血液制品后的疗效[2],国外广泛应用于心脏及肝手术、产科、血友病及高凝状态的患者。2004年血小板图(Platelet Mapping)的上市[3],实现了应用TEG来快速、准确地监测血小板聚集功能,进而评价抗血小板药物的疗效[4]。

关键词(KeyWords)： 血栓弹力图;经皮冠状动脉介入治疗;血小板功能

Abstract:

Keywords:

基金项目(Foundation):

作者(Author): 邱林,龚艳君

参考文献(References)：

• [1]Hartert H,Schaeder JA.The physical and biological constants of Thrombelastography.Biorheolgy,1962,1:31-39.
• [2]Reikvam H,STeien E,Hauge B,et al.Thrombelastography.Transfus Apher Sci,2009,40:119-123
• [3]Craft RM,Chavez JJ,Bresee SJ,et al.A novel modifi cation of the Thrombelastograph assay,isolating platelet function,correlates with optical platelet aggregation.J Lab Clin Med,2004,143:301-309.
• [4]李丹丹,任艺虹,杨庭树.改良血栓弹力图及其在辅助冠心病诊疗方面的研究进展.西南国防医药,2008,18:301-302.
• [5]Salooja N,Perry DJ.Thrombelastography.Blood Coagul Fibrinolysis,2001,12:327-337.
• [6]刘克玄,黄文起,陈秉学,等.血栓弹性描记仪的临床应用初探.现代医学仪器与应用,2000,12:11-13.
• [7]Bombeli T,Spahn DR.Updates in perioperative coagulation physiology and management of thromboembolism and haemorrhage.Br J Anaesth,2004,93:275-287
• [8]Artang R,Jensen E,Pedersen F,et al.Thrombelastography in Healthy Volunteers,Patients with Stable Angina and Acute Chest Pain.Thromb Res,2000,97:499-503.
• [9]Mittermayr M,Velik-Salchner C,Stalzer B,et al.Detection of protamine and heparin after termination of cardiopulmonary bypass by thrombelastometry(ROTEM):results of a pilot study.Anesth Analg,2009,108:743-750.
• [10]Gravlee GP,Case L,Angert KC,et al.Variability of the activated coagulation time.Anesth Analg,1988,67:469-472.
• [11]Wang JS,Lin CY,Karp RB.Comparison of high-dose thrombin time with activated clotting time for monitoring of anticoagulant effects of heparin in cardiac surgical patients.Anesth Analg,1994,79:9-13.
• [12]侯旭敏,戴锦杰,韩文正,等.血栓弹力图与活化凝血时间评价PCI术中普通肝素效果的比较研究.上海交通大学学报(医学版),2012,32:1486-1500.
• [13]Coppell JA,Thalheimer U,Zambruni A,et al.The effects of unfractionated heparin,low molecular weight heparin and danaparoid on the thromboelastogram(TEG):an in-vitro comparison of standard and heparinase-modified TEGs with conventional coagulation assays.Blood Coagul Finbrinolysis,2006,17:97-104.
• [14]Galeone A,Rotunno C,Guida P,et al.Monitoring incomplete heparin reversal and heparin rebound after cardiac surgery.J Cardiothorac Vasc Anesth,2013,27:853-858.
• [15]Artang R,Frandsen NJ,Nielsen JD.Application of basic and composite thrombelastography parameters in monitoring of the antithrombotic effect of the low molecular weight heparin dalteparin:an in vivo study.Thromb J,2009,7:14.
• [16]Carroll RC,Chavez JJ,Simmons JW,et al.Measurement of patients’bivalirudin plasma levels by a thrombelastograph ecarin clotting time assay:a comparison to a standard activated clotting time.Anesth Analg,2006,102:1316-1319.
• [17]Hobson AR,Agarwala RA,Swallow RA,et a1.Thrombelastography:current clinical applications and its potential role in interventional cardiology.Platelets,2006,17:509-518.
• [18]Mehta SR,Yusuf S,Peters RJ,et al.Effects of pretreatment with clopidogrel and aspirin followed by long-term therapy in patients undergoing percutaneous coronary intervention:the PCI-CURE study.Lancet,2001,385:527-533.
• [19]薛朝阳,陈媛,陆民.冠状动脉介入术对血小板活性的影响及与支架血栓的关系.中国介入心脏病学杂志,2009,17:320-323.
• [20]Wennaweser P,Dorffl er MJ,Imboden K,et al.Stent thrombosis is associated with an impaired response to antiplatelet therapy.J Am Coll Cardiol,2005,45:1748-1752.
• [21]Gurbel PA,Blinden KP,Guyer K,et al.Platelet reactivity in patients and recurrent events post-stenting:results of the PREPARE POSTSTENTING Study.J Am Coll Cardiol,2005,46:1820-1826.
• [22]Gurbel PA,Bliden KP,Kreutz RP,et al.The link between heightened thrombogenicity and infl ammation:pre-procedure characterization of the patient at high risk for recurrent events after stenting.Platelets,2009,20:97-104.
• [23]Kreutz RP,Owens J,Brealla JA.C-reactive protein and fi brin clot strength measured by thrombelastography after coronary stenting.Blood Coagul Fibrinolysis,2013,24:321-326.
• [24]Gurbel PA,Bliden KP,Navickas IA,et al.Adenosine diphosphateinduced platelet-fibrin clot strength:a new thrombelastographic indicator of long-term poststenting ischemic events.Am Heart J,2010,160:346-354.
• [25]Jeong YH,Bliden KP,Antonino MJ,et al.Usefulness of thrombelastography platelet mapping assay to measure the antiplatelet effect of P2Y12 receptor inhibitors and high on-treatment platelet reactivity.Platelets,2013,24:166-169.
• [26]Bliden KP,DiChiara J,Tantry US,et al.Increased risk in patients with high platelet aggregation receiving chronic clopidogrel therapy undergoing percutaneous coronary intervention:is the current antiplatelet therapy adequateJ Am Coll Cardiol,2007,49:657-666.
• [27]Tantry US,Bliden KP,Gurbel PA.Overestimation of platelet aspirin resistance detection by thrombelastograph platelet mapping and validation by conventional aggregometry using arachidonic acid stimulation.J Am Coll Cardiol,2005,26:1705-1709.
• [28]Liu XF,Cao J,Fan L,et al.Prevalence of and risk factors for aspirin resistance in elderly patients with coronary artery disease.J Geriatr Cardiol,2013,10:21-27.
• [29]Hou XM.Clinical Characteristics Related with High Ontreatment Platelet Reactivity Receiving Clopidogrel Measured by Thormbelastography in Patients undergoing Percutaneous Coronary Intervention.J Am Coll Cardiol,2012,59:E1405.
• [30]Sambu N,Radhakrishnan A,Dent H,et al.Personalised antiplatelet therapy in stent thrombosis:observations from the Clopidogrel Resistance in Stent Thrombosis(CREST)registry.Heart,2012,98:706-711.
• [31]任艺虹,盖鲁粤,杨庭树,等.改良血栓弹力图法和流式细胞测定技术对血小板活性抑制程度的比较.中华心血管病杂志,2007,35:366-367.
• [32]韩旭东,黄晓英,王芳,等.血栓弹力图预测肝病患者消化道出血的价值研究.临床消化病杂志,2010,22:131-134.